EUVIMEDEUVIMED entdecken
Open Access

Impact of High Lipoprotein(a) on Long‐Term Survival Following Coronary Artery Bypass Grafting

Shuo Yuan, Fangzhou Li iD, Heng Zhang, Juntong Zeng iD, Xiaoting Su, Jianyu Qu, Shen Lin, Dachuan Gu, Chenfei Rao, Yan Zhao, Zhe Zheng iD

Journal of the American Heart Association · 06.02.2024 · 13 (3)

DOI: 10.1161/jaha.123.031322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 06.02.2024. Verfasst von Shuo Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital National Center for Cardiovascular Diseases Beijing People's Republic of…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Atherosclerosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Lipoprotein(a) is a possible causal risk factor for atherosclerosis and related complications. The distribution and prognostic implication of lipoprotein(a) in patients undergoing coronary artery bypass grafting remain unknown. This study aimed to assess the impact of high lipoprotein(a) on the long‐term prognosis of patients undergoing coronary artery bypass grafting. Methods and Results Consecutive patients with stable coronary artery disease who underwent isolated coronary artery bypass grafting from January 2013 to December 2018 from a single‐center cohort were included. The primary outcome was all‐cause death. The secondary outcome was a composite of major adverse cardiovascular and cerebrovascular events. Of the 18 544 patients, 4072 (22.0%) were identified as the high‐lipoprotein(a) group (≥50 mg/dL). During a median follow‐up of 3.2 years, primary outcomes occurred in 587 patients. High lipoprotein(a) was associated with increased risk of all‐cause death (high lipoprotein(a) versus low lipoprotein(a): adjusted hazard ratio [aHR], 1.31 [95% CI, 1.09–1.59]; P =0.005; lipoprotein(a) per 1‐mg/dL increase: aHR, 1.003 [95% CI, 1.001–1.006]; P =0.011) and major adverse cardiovascular and cerebrovascular events (high lipoprotein(a) versus low lipoprotein(a): aHR, 1.18 [95% CI, 1.06–1.33]; P =0.004; lipoprotein(a) per 1‐mg/dL increase: aHR, 1.002 [95% CI, 1.001–1.004]; P =0.002). The lipoprotein(a)‐related risk was greater in patients with European System for Cardiac Operative Risk Evaluation

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseAtherosclerosisHumansLipoprotein(a)Treatment OutcomeCoronary Artery BypassRisk FactorsRetrospective Studies

Stichwörter der Autor:innen

arterial graftscoronary artery bypass graftingdeathlipoprotein(a)outcomes

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital National Center for Cardiovascular Diseases Beijing People's Republic of China.
  • State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China.
  • Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China.
  • Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing People's Republic of China.
  • National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Fuwai Central China Hospital Central China Branch of National Center for Cardiovascular Diseases Zhengzhou People's Republic of China.
  • Key Laboratory of Coronary Heart Disease Risk Prediction and Precision Therapy Chinese Academy of Medical Sciences Beijing People's Republic of China.

ORCID-Profile: Fangzhou Li, Juntong Zeng, Zhe Zheng

Zitieren

APA

Yuan, S., Li, F., Zhang, H., Zeng, J., Su, X., Qu, J., Lin, S., Gu, D., Rao, C., Zhao, Y., & Zheng, Z. (2024). Impact of High Lipoprotein(a) on Long‐Term Survival Following Coronary Artery Bypass Grafting. Journal of the American Heart Association, 13(3). https://doi.org/10.1161/jaha.123.031322

Vancouver

Yuan S, Li F, Zhang H, Zeng J, Su X, Qu J, et al. Impact of High Lipoprotein(a) on Long‐Term Survival Following Coronary Artery Bypass Grafting. Journal of the American Heart Association. 2024;13(3). doi:10.1161/jaha.123.031322

BibTeX
@article{Yuan2024,
  author = {Yuan, Shuo and Li, Fangzhou and Zhang, Heng and Zeng, Juntong and Su, Xiaoting and Qu, Jianyu and Lin, Shen and Gu, Dachuan and Rao, Chenfei and Zhao, Yan and Zheng, Zhe},
  title = {Impact of High Lipoprotein(a) on Long‐Term Survival Following Coronary Artery Bypass Grafting},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {3},
  doi = {10.1161/jaha.123.031322}
}
Kostenlos starten →